| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | f6113982-e3b7-4f42-ae6f-65374f00c7fa | 8 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Kmart Corporation Children's Mucus Relief Drug Facts | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Drug Facts | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Drug Facts | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 6959e24a-4709-46b3-9425-2a261d3bf03c | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | e04ac4fb-256d-4e38-902c-536e1093f74e | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 3bc870c2-e1db-44ca-9552-ea5981fd3c33 | 10 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 3a73b934-ea39-43c2-86bf-dfb88353b8bd | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | TRIACIN-C (Triprolidine HCl, Pseudoephedrine HCl, and Codeine Phosphate Syrup) | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CVS Pharmacy, Inc. Tussin CF Drug Facts | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 87074521-e76d-46fb-b0ab-dcbb0f891ec9 | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 6ce99730-887e-410e-8ac9-f9c96d0f4814 | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | cbd3b7dc-da04-4497-be3c-b94363d6876f | 20 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 8dd7ab8f-2cb0-4600-9f57-ab5cef171559 | 10 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 0d52ee7d-a955-4263-b53b-b697c3fa013d | 8 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | These highlights do not include all the information needed to use Oxycodone Hydrochloride safely and effectively. See full prescribing information for Oxycodone Hydrochloride. Oxycodone Hydrochloride (Oxycodone Hydrochloride) SOLUTION for ORAL use. Initial U.S. Approval: 1950 | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | e8828a43-e46e-40aa-b31b-19eac5aaac3b | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 2b5f6205-0861-4502-8b18-df10c957e78a | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | d682c413-b84c-4410-a3bb-096f525249f7 | 5 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Theophylline Oral Solution | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ERYTHROMYCIN PLEDGETS USP, 2% | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | Ache and Pain Relief to Go ™ | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | Upset Stomach Relief to Go ™ | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | Critical Care Aspirin to Go ™ | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 272f30af-1f4a-406b-a23a-0d955ed6a0bb | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Unknown Title | 1000 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | d75f9fcf-b6a8-4707-b5ab-4fb13755759c | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | fc2ea50b-6449-4403-ab8f-ce3d7d949b55 | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Childrens Allegra Allergy-ODT | 12 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | Nortemp Infants Drops | 12 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | FLUCONAZOLE Fluconazole Tablets Fluconazole for Oral Suspension | 13 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CLARITHROMYCIN TABLETS, USP AND CLARITHROMYCIN FOR ORAL SUSPENSION, USP Rx only | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 5678be04-5e19-4c87-8eca-5222b849660e | 10 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | f4fe65a0-a1de-4fed-a76e-a4571c36ef40 | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Famotidine for Oral Suspension, USP Novel Laboratories, Inc. | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 5dcd492f-cef1-41ba-b5d2-c79c31601f63 | 6 | |
| ANHYDROUS CITRIC ACID | ACTIVE INGREDIENT | XF417D3PSL | Drug Facts | 4 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | Drug Facts | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 8a4da72e-47bc-454b-b020-f23dcd4bb692 | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Ibuprofen Oral Suspension, USP (NSAID) Pain Reliever/ Fever Reducer 100 mg/ 5 mL | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | INFUVITE ® ADULT Multiple Vitamins for Infusion | 10 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN TABLETS USP Initial U.S. Approval: 1991 | 8 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | These highlights do not include all the information needed to use simvastatin tablets safely and effectively. See full prescribing information for simvastatin tablets. SIMVASTATIN TABLETS USP Initial U.S. Approval: 1991 | 8 | |
| CITRIC ACID ANHYDROUS | INACTIVE INGREDIENT | XF417D3PSL | e1f919d0-f4da-4312-a014-ccb6c0ecd04c | 4 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | Drug Facts | 9 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | Buprenorphine hydrochloride 8mg | 1002 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | BAYCADRON™ ELIXIR (Dexamethasone Elixir, USP 0.5 mg/5 mL) | 4 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | PRENATAL PLUS IRON (MULTIVITAMIN/MULTIMINERAL SUPPLEMENT) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 20091049 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | NAPRELAN (NAPROXEN SODIUM) TABLET, FILM COATED, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3264 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | NORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.] | 1509 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK] | 1004 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CLARITHROMYCIN TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1003 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE) TABLET [BRYANT RANCH PREPACK] | 1000 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | LUDENT (SODIUM FLUORIDE) TABLET, CHEWABLE [BRYANT RANCH PREPACK] | 1000 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | PROMETHAZINE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE SYRUP [BRYANT RANCH PREPACK] | 1000 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ] | 130 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | BUPRENORPHINE HYDROCHLORIDE TABLET [REMEDYREPACK INC. ] | 130 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP] | 41 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | REVATIO (SILDENAFIL CITRATE) TABLET, FILM COATED REVATIO (SILDENAFIL CITRATE) INJECTION, SOLUTION REVATIO (SILDENAFIL CITRATE) POWDER, FOR SUSPENSION [PFIZER LABORATORIES DIV PFIZER INC] | 33 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | PRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP] | 29 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | VFEND (VORICONAZOLE) TABLET, FILM COATED VFEND (VORICONAZOLE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION VFEND (VORICONAZOLE) POWDER, FOR SUSPENSION [ROERIG] | 27 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | TORISEL (TEMSIROLIMUS) KIT [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 26 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | VIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.] | 26 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DOCETAXEL INJECTION, SOLUTION, CONCENTRATE [ACTAVIS PHARMA, INC.] | 25 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | BANZEL (RUFINAMIDE) TABLET, FILM COATED BANZEL (RUFINAMIDE) SUSPENSION [EISAI INC.] | 24 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | LEVETIRACETAM SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 23 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DIFLUCAN (FLUCONAZOLE) TABLET DIFLUCAN (FLUCONAZOLE) POWDER, FOR SUSPENSION [ROERIG] | 22 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | UP AND UP DM MAX COUGH PLUS CHEST CONGESTION (DEXTROMETHORPHAN HBR, GUAIFENESIN) SUSPENSION [TARGET CORPORATION] | 22 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DILANTIN-125 (PHENYTOIN) SUSPENSION [PARKE-DAVIS DIV OF PFIZER INC] | 21 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | OXYCODONE HYDROCHLORIDE SOLUTION [LANNETT COMPANY, INC.] | 20 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | SIMVASTATIN TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 20 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | MORPHINE SULFATE SOLUTION, CONCENTRATE [LANNETT COMPANY, INC.] | 19 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | HEPARIN SODIUM IN DEXTROSE (HEPARIN SODIUM AND DEXTROSE) INJECTION [B. BRAUN MEDICAL INC.] | 18 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | LEVETIRACETAM SOLUTION [SILARX PHARMACEUTICALS, INC] | 18 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | FLUCONAZOLE TABLET FLUCONAZOLE POWDER, FOR SUSPENSION [GREENSTONE LLC] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | HEPARIN SODIUM INJECTION, SOLUTION [HOSPIRA, INC.] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | METHYLIN (METHYLPHENIDATE HYDROCHLORIDE) SOLUTION [SHIONOGI INC.] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | RISPERIDONE SOLUTION [QUALITEST PHARMACEUTICALS] | 17 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILPHEN (DIPHENHYDRAMINE HYDROCHLORIDE) SYRUP [SILARX PHARMACEUTICAL, INC] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ZIAGEN (ABACAVIR SULFATE) TABLET, FILM COATED ZIAGEN (ABACAVIR SULFATE) SOLUTION [VIIV HEALTHCARE COMPANY] | 17 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, FILM COATED AMOXICILLIN AND CLAVULANATE POTASSIUM POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC] | 16 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | BROTAPP (BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SILARX PHARMACEUTICALS, INC] | 16 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | BROVANA (ARFORMOTEROL TARTRATE) SOLUTION [SUNOVION PHARMACEUTICALS INC.] | 16 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DIGOXIN INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 16 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | DIGOXIN INJECTION, SOLUTION [SANDOZ INC] | 16 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM) INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | OXYBUTYNIN CHLORIDE SYRUP [SILARX PHARMACEUTICALS, INC] | 16 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILTUSSIN DM (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS,INC] | 16 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ACETAMINOPHEN AND CODEINE PHOSPHATE SOLUTION [HI-TECH PHARMACAL CO., INC.] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ANALPRAM E (HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE) CREAM [FERNDALE LABORATORIES, INC.] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE) TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CEFPODOXIME PROXETIL GRANULE, FOR SUSPENSION [SANDOZ INC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ESCITALOPRAM OXALATE (ESCITALOPRAM) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ONDANSETRON (ONDANSETRON HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 15 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | RISPERDAL CONSTA (RISPERIDONE) KIT [JANSSEN PHARMACEUTICALS, INC.] | 15 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILTUSSIN SA (GUAIFENESIN) LIQUID [SILARX PHARMACEUTICALS, INC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ZOFRAN (ONDANSETRON HYDROCHLORIDE) SOLUTION ZOFRAN ODT (ONDANSETRON HYDROCHLORIDE) TABLET, ORALLY DISINTEGRATING ZOFRAN (ONDANSETRON HYDROCHLORIDE) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | 15 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | APRISO (MESALAMINE) CAPSULE, EXTENDED RELEASE [SALIX PHARMACEUTICALS, INC.] | 14 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CLARINEX (DESLORATADINE) TABLET, FILM COATED CLARINEX (DESLORATADINE) SOLUTION [MERCK SHARP & DOHME CORP.] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | EPIVIR HBV (LAMIVUDINE) TABLET, FILM COATED EPIVIR HBV (LAMIVUDINE) SOLUTION [GLAXOSMITHKLINE LLC] | 14 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | INFANTS SILAPAP (ACETAMINOPHEN) SOLUTION/ DROPS [SILARX PHARMACEUTICALS, INC] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | METRONIDAZOLE INJECTION, SOLUTION [HOSPIRA, INC.] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | PULMICORT RESPULES (BUDESONIDE) SUSPENSION [ASTRAZENECA LP] | 14 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILACE (DOCUSATE SODIUM) SYRUP [SILARX PHARMACEUTICALS,INC] | 14 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILADRYL ALLERGY MEDICINE (DIPHENHYDRAMINE HYDROCHLORIDE) LIQUID [SILARX PHARMACEUTICALS, INC] | 14 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | SILTUSSIN DM DAS COUGH FORMULA (GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | SIMVASTATIN TABLET, FILM COATED [ZYDUS PHARMACEUTICALS (USA) INC.] | 14 | |
| Anhydrous Citric Acid | INACTIVE INGREDIENT | XF417D3PSL | ULTRAGREEN ANTIBACTERIAL (TRICLOSAN) LIQUID [DEB USA, INC.] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | ZOMIG (ZOLMITRIPTAN) TABLET ZOMIG ZMT (ZOLMITRIPTAN) TABLET, ORALLY DISINTEGRATING [ASTRAZENECA PHARMACEUTICALS LP] | 14 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | AMOXICILLIN CAPSULE AMOXICILLIN TABLET, FILM COATED AMOXICILLIN POWDER, FOR SUSPENSION [SANDOZ INC] | 13 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | BROTAPP DM COLD AND COUGH (BROMPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE) LIQUID [SILARX PHARMACEUTICALS, INC] | 13 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CHILDRENS SILFEDRINE (PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [SILARX PHARMACEUTICALS, INC] | 13 | |
| Anhydrous Citric Acid | ACTIVE INGREDIENT | XF417D3PSL | CPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 13 | |
| Anhydrous Citric Acid | ACTIVE MOIETY | XF417D3PSL | CPD/ADSOL (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.] | 13 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | HYOSYNE (HYOSCYAMINE SULFATE) ELIXIR [SILARX PHARMACEUTICALS, INC] | 13 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | KINERET (ANAKINRA) INJECTION, SOLUTION [SWEDISH ORPHAN BIOVITRUM AB (PUBL)] | 13 | |